Characterizing complex and competing drug-drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine.
Saved in:
| Title: | Characterizing complex and competing drug-drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine. |
|---|---|
| Authors: | Kosloski MP; Clinical Pharmacology, AbbVie Inc., North Chicago, Illinois, USA., Li H; Data and Statistical Sciences, AbbVie Inc., North Chicago, Illinois, USA., Wang S; Infectious Disease, AbbVie Inc., North Chicago, Illinois, USA., Mensa F; Infectious Disease, AbbVie Inc., North Chicago, Illinois, USA., Kort J; Medical Affairs, AbbVie Inc., North Chicago, Illinois, USA., Liu W; Clinical Pharmacology, AbbVie Inc., North Chicago, Illinois, USA. |
| Source: | Clinical and translational science [Clin Transl Sci] 2023 Apr; Vol. 16 (4), pp. 593-605. Date of Electronic Publication: 2023 Jan 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1752-8062 |
|---|---|
| DOI: | 10.1111/cts.13471 |
